The Patent Finder

Entasis Therapeutics Limited

Also on record
Records under this name other than the patents Entasis Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 5 of 5 · Back to Entasis Therapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,623,014Beta-Lactamase Inhibitor Compounds
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,238,661Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
Lapsed on the fee record
Ended Mar 26, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 26, 2023USPTO record
US 7,439,253Novel Heterocyclic Compounds, Their Preparation and Their Use as Medicaments, in Particular as Antibacterials and Beta-Lactamase Inhibitors
Lapsed on the fee record
Ended Oct 21, 2020 · Medium confidence
Lapsed on the fee recordEnded Oct 21, 2020Medium confidence
US 8,148,540Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
Lapsed on the fee record
Ended Apr 3, 2020 · USPTO record
Lapsed on the fee recordEnded Apr 3, 2020USPTO record
US 7,288,549Novel Heterocyclic Compounds, Method for Preparing Same and Use Thereof as Medicines, in Particular as Antibacterial Agents
Lapsed on the fee record
Ended Oct 30, 2019 · Medium confidence
Lapsed on the fee recordEnded Oct 30, 2019Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited